Syncom Formulations Limited Share Price Target 2025, 2030, 2035, 2040, 2045, 2050

Invest In, Stocks, Technical Analysis

Syncom Formulations Limited: A Comprehensive Overview

The Syncom Formulations Limited is one of the crucial stakeholders in India’s pharmaceutical markets, with an aim of providing quality heath care services. Analyzing the services and products which Syncom has to offer, the quality of services, the market segment it covers the financial perspective of Syncom and finally the long term forecast of share price for Syncom will be beneficial for investors and stakeholders.

A Brief History

Syncom Formulations Limited is a growing company that has emerged in India since the beginning of the 1990s. Principal activity: Intense on research and development, the company went a notch higher bringing quality pharmaceutical products to the international market.

Products and Services

Syncom Formulations Limited offers a diverse portfolio of pharmaceutical products, including:

Tablets and Capsules
It can be prescribed for pain relief, infections, and long-term illness.
Injectables
Special product designs for the intensive care and immediate care environment.
Syrups and Suspensions
Medicines have the added feature of being easily taken especially when they have reached their weaning period.

Commitment to Quality

Syncom Formulations Limited places a strong emphasis on maintaining high standards of quality, reflected in its certifications:

WHO Certification: Keeps products safe for use and to customers and patient and effective.
GMP Certification: Ensures compliance to GMP to facilitate a consistent product quality.

Market Presence

Today, Syncom Formulations Limited has a diverse distribution network in the domestic as well as the global marketplace and it works with hospitals and distributors worldwide to make its products easily available to everyone.

Financial Performance

Being a listed company, the Syncom Formulations proves that it has stabilized its financial parameters. For this reason, the performance of the company has been steady due to the commitment of new approaches in delivery of its goods and services and quality.

Future Prospects

Syncom Formulations aims to drive growth through:

Entrepreneurial orientation in terms of adopting high levels of technological innovation.
Venturing into currently unexplored markets for the firm.
Expanding human resource development to produce customers oriented products.

Year	Projected Price Range (₹)
2024	11.70 – 26.80
2025	27.60 – 43.50
2026	45.75 – 72.87
2027	75.00 – 105.25
2028	108.50 – 150.00
2029	154.50 – 200.00
2030	205.00 – 260.50

Long-Term Predictions (2035-2050)

Year	Projected Price Range (₹)
2035	505.00 – 560.00
2040	805.00 – 860.00
2050	1,405.00 – 1,460.00

Fundamental Analysis

Metric	Value
Market Cap	₹2,187.38 Cr
Promoter Holding	50.57%
Sales Growth	2.27%
ROCE	9.68%
Debt	₹83.18 Cr
EPS (TTM)	₹0.29
P/E Ratio	81
Dividend Yield	0%

Shareholding Pattern

Category	Percentage
Promoters	50.57%
Retail & Others	49.43%

FAQs

1. Where does Syncom Formulations get its revenue from?
Syncom Formulations Limited therefore specialises in the production of pharmaceutical products such as tablets, injectables and syrups, among others.

2.Should I buy Syncom Formulations?
It’s important for long-term investors since it has presented a constant growth and is seeking to strengthen its position on the market. However, more research and analyst should be conducted before investing in any of the stocks.

3. Which certifications does Syncom possess?
Syncom also comply with WHO and GMP standard which assure the company of good quality production.

4. Where can I acquire Syncom Formulations shares?
To purchase the Syncom shares you can approach any of the NSE or BSE brokers to purchase at the respective stock exchange.

5. That leads to the next questions about the company regarding its future growth plans of Syncom?
With these objectives, the company wants to harness new technologies, enter new markets and scale up the company’s R&D.

The Syncom Formulations Share Price Prediction 2025 is 27.60 – 43.50INR.

The Syncom Formulations Share Price Prediction 2026 is 45.75 – 72.87INR.

The Syncom Formulations Share Price Prediction 2027 is 75.00 – 105.25INR.

The Syncom Formulations Share Price Prediction 2028 is 108.50 – 150.00INR.

The Syncom Formulations Share Price Prediction 2029 is 154.50 – 200.00INR.

The Syncom Formulations Share Price Prediction 2030 is 205.00 – 260.50INR.

The Syncom Formulations Share Price Prediction 2035 is 505.00 – 560.00INR.

The Syncom Formulations Share Price Prediction 2040 is 805.00 – 860.00INR.

The Syncom Formulations Share Price Prediction 2050 is 1,405.00 – 1,460.00INR.

Conclusion

This research work has further strengthened the findings to reveal Syncom Formulations Limited as a reliable and innovative pharma firm. Thanks to the clear long-term plan of development and due focus on high level of product quality, it is able to build a sustainable future in national and international contexts. To get the most current information visit the official website of the company or follow their financial statements.

Disclaimer

This article is not meant to be used as a source of financial advice or information. The projections and data are, to the extent, possible and reasonable, based on information that is publicly available and analysis. Prices in the stock market are volatile, and the past performance should not be a factor of predicting future results. Based on such a decision, one should seek the assistance of a financial expert before investing.

Investing View